Explore evidence

27.78 per_100_person_yearsIncidence of mortality showed a reducing trend and ranged from 27.78 per 100 person-years in 2020 to 0.81 per 100 person-years in 2022.

NigeriaVIH/sidaobserved 2020published 2025PloS onePubMeddocument of 8 observations

95 %The HIV testing coverage among adolescents and young adults (AYA) in Nigeria is well below the national target of 95% indicated in the national HIV/AIDS strategic framework (2017–2021).

NigeriaVIH/sidaobserved 2017-2021published 2020PloS onePubMeddocument of 4 observations

69.4 %Primary prevention of HIV (PPV) had the highest 'yes' willingness to pay (WTP) response of 152 (69.4%).

NigeriaVIH/sidapublished 2021Journal of clinical pharmacy and therapeuticsPubMeddocument of 5 observations

50 %Over 50% of global HIV infection and deaths occur in sub-Saharan Africa.

NigeriaVIH/sidapublished 2021Journal of medical virologyPubMeddocument of 11 observations

4 casesCataract was the predominant cause of blindness in 4 (3.5%) cases.

Nigeriacataract · VIH/sidapublished 2023West African journal of medicinePubMeddocument of 9 observations

7.3 %7.3% of respondents experienced all forms of stigma.

NigeriaVIH/sidapublished 2022The Pan African medical journalPubMeddocument of 12 observations

11.88 %HIV seroprevalence among people who inject drugs (PWID) in Nigeria was 11.88% (1126 out of 9474) between October 1, 2016, and September 30, 2017.

NigeriaVIH/sidaobserved October 1, 2016 to September 30, 2017published 2021JMIR public health and surveillancePubMeddocument of 6 observations

3.3 log_copies_per_mLThe mean HIV-1 RNA level was 3.3 ± 1.3 log copies/mL.

NigeriaVIH/sidapublished 2020AIDS research and therapyPubMeddocument of 12 observations

10.33 foldCD4 counts among the Moringa oleifera group were 10.33 folds greater than the control group over the study period.

NigeriaVIH/sidapublished 2021PloS onePubMeddocument of 5 observations

31.4 %Among 229 HIV-1 positive individuals, 31.4% were ART-naïve.

NigeriaVIH/sidaobserved May 2023 to August 2024published 2025AIDS research and therapyPubMeddocument of 7 observations

96 %Disclosure was higher among respondents in non-peer support groups (96%) compared to 94.5% in peer support groups.

NigeriaVIH/sidapublished 2019The Pan African medical journalPubMeddocument of 2 observations

18.7 %Approximately 18.7% of men had tested for HIV in the last 12 months preceding the 2016/2017 Multiple Indicator Cluster Survey in Nigeria.

NigeriaVIH/sidaobserved 2016/2017published 2020AIDS carePubMeddocument of 5 observations

40.8 %HIV prevalence among cis-gender men who have sex with men (cis-MSM) in Abuja and Lagos, Nigeria was 40.8%.

NigeriaVIH/sidaobserved 2013 to 2020published 2022Journal of the International AIDS SocietyPubMeddocument of 20 observations

2,384 parasites/μLThe mean parasite density was 2384 ± 747 in HIV-seropositive participants in Warri community, South-Southern Nigeria.

NigeriaVIH/sidapublished 2021African health sciencesPubMeddocument of 2 observations

92.5 %The majority of respondents from the south-west of Nigeria had good knowledge about ART, at 92.5%.

NigeriaVIH/sidapublished 2022African journal of AIDS research : AJARPubMeddocument of 4 observations

94 %94% of participants demonstrated satisfactory knowledge of antiretroviral therapy.

NigeriaVIH/sidapublished 2025BMC public healthPubMeddocument of 6 observations

0 per_100_person_yearsThe HIV incidence per 100 person-years was zero in the general outpatient clinic model.

NigeriaVIH/sidapublished 2022PloS onePubMeddocument of 6 observations

5.9 %Among 17 HIV-infected, HIV-exposed infants in Plateau State, Nigeria who experienced treatment mortality or losses (TX_ML), 5.9% (1/17) interrupted treatment.

NigeriaVIH/sidaobserved 2018–2022published 2026PloS onePubMeddocument of 13 observations

56.2 %Among 352 participants living with HIV/AIDS on antiretroviral therapy in a Nigerian tertiary hospital, 56.2% had a CD4 count fewer than 500 cells/mm.

NigeriaVIH/sidapublished 2021Value in health regional issuesPubMeddocument of 4 observations

4.5 %The prevalence of abnormal ECG findings in HIV-negative children was 4.5%.

NigeriaVIH/sidapublished 2020The Nigerian postgraduate medical journalPubMeddocument of 9 observations

24.4 %HIV testing uptake among undergraduate students in Imo State, Nigeria, was 24.4% at Imo State University (IMSU) in the past year.

NigeriaVIH/sidapublished 2026Scientific reportsPubMeddocument of 5 observations

686,000,000 USDPrioritizing HIV within the health budget in Nigeria can generate an additional US$ 686 million.

NigeriaVIH/sidapublished 2023Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 5 observations

9.96 fold_increaseThe intervention led to a 9.96-fold increase in HIV self-testing uptake compared to the control period.

NigeriaVIH/sidapublished 2025Contemporary clinical trialsPubMeddocument of 8 observations

99 %OSS achieved a viral load suppression rate of 99.0%.

NigeriaVIH/sidaobserved May 2022 to May 2023published 2026BMC public healthPubMeddocument of 9 observations

16 %Of the 160 patients with mpox, 25 (16%) had HIV in Nigeria during the study period from Feb 1, 2022, to Jan 30, 2023.

Nigeriampox · VIH/sidaobserved Feb 1, 2022, to Jan 30, 2023published 2023The Lancet. Infectious diseasesPubMeddocument of 11 observations